According to a report by Grand View Research, Inc.; the global CELL LINE DEVELOPMENT MARKETis projected to reach a valuation of around USD 6.24 billion by 2022.Rising demand for monoclonal antibodies and availability of advanced techniques to develop new cell lines can propel the market during the forecast period (2012 to2022).Additionally, factors such as growing adoption... Continue Reading →